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The aim of this study was to investigate the effects of oral melatonin on oxidative/antioxidative parameters and 
histopathological changes in the hippocampal tissue of Cd-exposed Wistar rats, including malondialdehyde (MDA), 
glutathione (GSH), tumour necrosis factor-alpha (TNF-α), interleukin (IL-6 and IL-10), and gamma-aminobutyric acid 
(GABA) levels and catalase (CAT), superoxide dismutase (SOD), and acetylcholinesterase (AChE) activities. Thirty-two 
male Wistar rats were divided randomly into four groups as follows: untreated control (n=8), cadmium (Cd) (n=8), 
melatonin (Mlt) (n=8), and Cd+Mlt (CdMlt) (n=8). Cd (2 mg/kg) was administered orally by gastric gavage three times 
a week and Mlt (100 mg/kg) five times a week. The control group received standard feed and water only. After four weeks 
of treatment, the animals were decapitated and tissue samples taken for biochemical and histopathological evaluations. 
Mlt caused a significant increase in GSH levels and SOD and CAT activities in the CdMlt group compared to the Cd 
group. Tissue TNF-α and IL-6 levels were significantly higher in the Cd group than other groups (P<0.05). This effect 
was significantly countered by Mlt in the CdMlt group (P<0.05). GABA concentrations were significantly higher in the 
Mlt than other groups (P<0.05). Our findings clearly evidence the protective effects of melatonin against Cd-induced 
neurotoxicity in rats.
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The main sources of occupational exposure to cadmium 
(Cd) are metal industries (mining, smelting, processing, 
product formulations, and battery manufacturing), while 
the sources of non-occupational exposure include 
contaminated air (smoking included), water, soil, plants, 
and food. Exposure through skin, however, is rare (1–3).
Although the main target organs of Cd poisoning are 
the kidney and the liver, in chronic exposure Cd can also 
accumulate in different parts of the central nervous system 
(CNS) by damaging and passing the blood-brain barrier 
(BBB) or through nasal mucosa or olfactory pathways (4, 
5). There it causes oxidative stress and through it 
neurotransmitter dysfunction and hippocampus-dependent 
learning and memory impairment in humans and animals 
(6–8). It has also been implicated in the development of 
Alzheimer’s and Parkinson’s disease (9).
In recent years, research has been focused on how to 
counter the harmful oxidative effects of Cd and has included 
a number of substances with antioxidant and metal-binding 
properties, especially in Cd-exposed animals (10–12). One 
of them is melatonin (n-acetyl-5-methoxytryptamine), a 
hormone secreted mainly from the pineal gland with 
powerful metal-binding (13), antioxidant (14), and free 
radical scavenging (15) properties due to its small size and 
lipophilicity. Recent studies have also shown that melatonin 
plays a neuroprotective role in many central nervous system 
(CNS) disorders, including Alzheimer’s and Parkinson’s 
disease and ischaemic brain injury. It has also shown 
beneficial effects on memory, posture control, and balance 
(16) and was reported to protect against Cd-induced 
neurotoxicity in rats by reducing lipid peroxidation and 
res tor ing ant ioxidant  defence parameters  and 
acetylcholinesterase (AChE) activity in the plasma and 
brain (17).
Considering the important role of the hippocampus in 
spatial navigation, emotional behaviour, regulation of 
hypothalamic functions, learning, memory, limbic system 
(18–20), and its damage in Alzheimer’s disease (20, 21), 
we wanted to complement relatively modest literature (14, 
22–24) about beneficial effects of oral melatonin in the 
hippocampus, especially in regard to cytokines and gamma-
aminobutyric acid (GABA) levels. To that effect the aim of 
our study was to compare common oxidative stress, 
i n f l ammat ion ,  and  neuro tox ic i ty  pa ramete r s 
[malondialdehyde (MDA) (25), interleukins 6 and 10 (IL-
6, IL-10), tumour necrosis factor alpha (TNF-α) (9, 26–28), 
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GABA (29–36), acetylcholinesterase (AChE) (17, 37, 38)] 
and antioxidant defence parameters [glutathione (GSH), 
superoxide dismutase (SOD), and catalase (CAT) (39)] in 
the hippocampal tissue of control, Cd-, and melatonin-
treated rats. We also wanted to investigate potential 
neuroprotect ive  effects  of  melatonin  through 
histopathological changes in the cerebral cortex of rats 
exposed to Cd.
MATERIALS AND METHODS
Animals and experimental design
Three weeks old male albino Wistar rats weighing 
~200±30 g (n=32), purchased from Balıkesir University 
Experimental Medicine Research and Application Center 
(BUEMRAC), were first acclimatised to laboratory 
conditions for two weeks and then divided randomly into 
four groups: untreated control, cadmium (Cd), melatonin 
(Mlt), and Cd+Mlt (CdMlt), each consisting of eight 
animals. The rats were housed in standard plastic rat cages 
in an air-conditioned room (at 23±2 °C and 55±10 % 
humidity) with a 12-hour light/dark cycle. They had free 
access to standard pellet diet and fresh water.
The animals in the Cd and CdMlt groups received 2 mg/
kg of Cd (Cat. No: 1002283736; CdCl2) by gavage (1 mL/
kg bwt) three times a week for four weeks, as described 
elsewhere (40). Those in the Mlt and CdMlt groups were 
receiving 100 mg/kg of melatonin (Cat. No: 1002042514) 
also by gavage five times a week for four weeks, as 
described elsewhere (41). The control group received only 
standard feed and water. After the four-week treatment, rats 
were sacrificed under anaesthesia with intraperitoneal 
injection of ketamine/xylazine (0.1 mL/100g/bwt) and then 
decapitated. Hippocampal/cerebral cortex tissue samples 
for biochemical and histopathological investigations were 
taken immediately. All animal procedures were approved 
and conducted in line with the guidelines of the Balıkesir 
University Experimental Animal Tests Local Ethics 
Committee (approval No. 2018/2-2).
Hippocampal tissue MDA, GSH, CAT, and SOD 
measurements
Hippocampal tissue samples of the animals were placed 
in liquid nitrogen and stored at -80 °C until analysis. 200 mg 
of each tissue sample in 800 mL of isotonic sodium chloride 
solution was homogenised at 9961 g in an ultrasonic 
homogeniser (IKA-T25, Merck, Darmstadt, Germany) and 
centrifuged at 4025 g for 10 min (Sigma18-K, Newtown, 
Shropshire, UK) to obtain supernatants. MDA and GSH 
levels and CAT and SOD activities were determined in the 
supernatants with the enzyme-linked immunosorbent assay 
(ELISA) using the ELx800 absorbance microplate reader 
(Biotek Instruments, Winooski, VT, USA) and standard 
commercial kits (Cat. Nos. 10009055, 703002, 707002, and 
706002, respectively; Cayman, Ann Arbor, MI, USA).
Hippocampal tissue cytokine measurements
IL-6, IL-10, and TNF-α were also detected in the 
obtained supernatants with ELISA (ELx800, Biotek) and 
commercial kits (Cat. Nos. BMS625, BMS629, and 
KRC3011, respectively; ThermoFisher Scientific, San Jose, 
CA, USA) according to the manufacturers’ instructions.
Hippocampal tissue GABA and AChE measurements
GABA concentrations were measured using the double-
sandwich ELISA kit (Sunred Biological Technology, 
Shanghai, China) according to the manufacturer’s 
instruction. In brief, tissue samples (supernatants) and kit 
standards (Cat. No: 201-11-0103) were extracted on an 
extraction plate, derived using an equalising reagent, and 
subjected to ELISA in GABA pre-coated microtitre strips. 
The absorbance of the solution in the wells was read at 
450 nm within 15 min with a Multiskan FC microplate 
reader (ThermoFisher Scientific). GABA concentrations 
were calculated based on optical density using a standard 
curve.
AChE activities were also determined using a sandwich 
ELISA kit (Elabscience, Wuhan, China) according to the 
producer’s instruction. Micro plates provided in this kit 
were pre-coated with an antibody specific to rat AChE (Cat. 
No: E-EL-R0355). The absorbance of the solution was 
immediately read at 450 nm with the above mentioned plate 
reader.
Cerebral cortex histopathology
Brain tissue samples (cerebral cortex) collected for 
histopathology were fixed in 10 % buffered formaldehyde 
solution, embedded in paraffin and cut into 4 µm thick 
sections, stained with haematoxylin and eosin (H&E), and 
observed under a light microscope (100x, Nikon, Eclipse 
Ni, Tokyo, Japan).
In situ TUNEL assay in the cerebral cortex
To identify apoptotic cells in the cerebral cortex we used 
the DeadEnd™ Colorimetric TUNEL System (Cat No: 
G7130; Promega, Madison, WI, USA) according to the 
manufacturer’s instructions.
Statistical analysis
All statistical analyses were run on IBM SPSS v. 25.0 
for Windows (IBM Corp., Armonk, NY, USA) starting with 
the analysis of variance (ANOVA) followed by Duncan’s 
test. P values ≤0.05 were considered significant.
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RESULTS
Table 1 shows hippocampal tissue MDA and GSH levels 
and SOD and CAT activities. MDA levels were the highest 
in the Cd group compared to the rest (P<0.05). The oxidative 
stress was significantly reduced by melatonin in the CdMlt 
compared to the Cd group (P<0.05). As expected, GSH 
levels and SOD and CAT activities were the lowest in the 
Cd group, but melatonin treatment improved them 
significantly in the CdMlt compared to the Cd group 
(P<0.05).
Table 2 shows cytokine levels in the hippocampal tissue 
of our rats. TNF-α and IL-6 levels significantly increased 
in the Cd group (P<0.05), while IL-10 levels dropped 
compared to the other groups (P<0.05). Again, melatonin 
significantly countered these effects of Cd (P<0.05).
Hippocampal tissue GABA concentrations were 
significantly lower in the Cd group than the other groups 
(P<0.05), but were increased by melatonin in the Mlt and 
CdMlt groups compared to the Cd group (P<0.05). 
However, we found no significant differences in AChE 
activities between the groups (Table 3).
Histopathological findings in the cerebral cortex
The control group showed normal histomorphology 
(Figure 1a), while the Cd group had severe multifocal 
histopathological changes in the cerebral cortex. In this 
location, most of the pyramidal and granular cells were 
shrunken and had pericellular halos and dark stained nuclei 
with lost nucleoli. Many vacuoles of variable sizes were 
noted in some granule cells and the neuropil tissue. These 
vacuolar changes were most prominent in the pyramidal 
layer but were also evident in other layers. Hyperaemia was 
also noted in some locations (Figure 1b). In the CdMlt 
group, some pyramidal and granular cells showed signs of 
cellular degeneration. A vacuolar halo around cells with 
shrunken nuclei was also seen in this group (Figure 1c). 
Hyperaemia was not observed. Only a few multifocal areas 
with these cellular changes were observed compared to the 
many in the Cd group. No histopathological changes were 
identified in the Mlt group (Figure 1d).
Figure 2 shows apoptotic granular cells, identified only 
in the Cd group (Figure 2). No apoptotic (TUNEL-stained) 
cells were observed in other groups.
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Figure 1 Typical H&E-stained histological images of cerebral cortex sections in Wistar rats by groups (a) normal histological appearance 
in the control group; (b) pyramidal cells irregular in shape, surrounded by pericellular halos (arrows) and intracellular vacuoles 
(arrowhead) in the Cd group; (c) more or less normal pyramidal and granular cells and intracellular (arrow) and extracellular vacuoles 
(arrowhead) in the CdMlt group; (d) histological appearance in the Mlt group















MDA (ng/mL) 1.717±0.016c 1.738±0.020c 1.785±0.013b 1.877±0.038a
SOD (ng/mL) 0.434±0.022a 0.432±0.016a 0.420±0.027a 0.390±0.014b
GSH (µg/mL) 2.170±0.094a 2.177±0.066a 2.013±0.086b 1.136±0.009c
CAT (U/L) 4.616±0.361a 4.697±0.463a 4.486±0.145ab 4.126±0.551b
a−c Means in the same row with different superscripts differ significantly (P<0.05). Mlt – group receiving melatonin alone; Cd – group 
receiving cadmium alone; CdMlt – group receiving both melatonin and cadmium. MDA – malondialdehyde; SOD – superoxide 
dismutase; GSH – glutathione; CAT – catalase; SD – standard deviation
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DISCUSSION
It is well known that the brain tissue is susceptible to 
lipid peroxidation due to high use of oxygen and 
polyunsaturated fatty acids. Our study confirms numerous 
findings of adverse Cd effects in this respect, showing 
significant increases in MDA (22, 24, 42, 43) levels and 
MDA lowering effects in the hippocampal tissue thanks to 
melatonin administration (42). Several studies have also 
reported these effects of melatonin in the hippocampal and 
brain tissue against arsenic (As) and aluminium (Al) 
poisoning (15, 23, 44).
The same is true for antioxidant response, which is 
severely affected by Cd (17, 39, 43, 45). Oral administration 
of melatonin in our study significantly increased and nearly 
restored GSH, SOD, and CAT, which is in line with earlier 
findings (17, 42, 44), evidencing its antioxidant action.
Of particular interest is the anti-inflammatory action of 
melatonin found in our study. Melatonin treatment reversed 
the elevated levels of TNF-α and IL-6 in the hippocampal 
tissue of animals receiving Cd, which adds new, even though 
expected, knowledge, as little has been reported about 
melatonin effects on IL- 6 and TNF-α levels in the 
hippocampus of rats exposed to Cd. Other studies found 
beneficial effects of melatonin in rats with induced breast 
cancer (46) or against aluminium (23), arsenic (44), and 
fluoride (47). As for IL-10, a regulatory cytokine which has 
both immunosuppressive and immunostimulatory 
properties, our findings confirm earlier reports of inhibitory 
effects of Cd in rat brain (9, 48) and beneficial effects of 
melatonin (49), which highlight the immunomodulatory 
potential of melatonin against chronic Cd poisoning (50).
In line with earlier reports on the GABA-lowering 
effects of Cd (35, 36), our study found the lowest GABA 














TNF-α (pg/mL) 0.070±0.001c 0.070±0.001c 0.081±0.002b 0.095±0.001a
IL-6 (pg/mL) 0.058±0.003b 0.116±0.171ab 0.125±0.191ab 0.217±0.107a
IL-10 (pg/mL) 0.256±0.004a 0.259±0.019a 0.252±0.005a 0.207±0.003b
a−c Means in the same row with different superscripts differ significantly (P<0.05). Mlt – group receiving melatonin alone; Cd – group 
receiving cadmium alone; CdMlt – group receiving both melatonin and cadmium. TNF-α – tumour necrosis factor alpha; IL-6 – 
interleukin 6; IL-10 – interleukin 10; SD – standard deviation















GABA (nmol/L) 8.124±0.008b 9.610±0.107a 7.174±0.082c 6.252±0.012d
AChE (ng/mL) 0.781±0.001 0.781±0.001 0.780±0.001 0.780±0.001
a−d Means in the same row with different superscripts differ significantly (P<0.05). Mlt – group receiving melatonin alone; Cd – group 
receiving cadmium alone; CdMlt – group receiving both melatonin and cadmium. AChE – acetylcholinesterase; GABA – gamma-
aminobutyric acid; SD– standard deviation
Figure 2 Section showing apoptotic cells (marked with arrows) in the granular layer of a Cd-treated rat (TUNEL method)
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hippocampal tissue concentrations in the Cd group. Similar 
was reported for the hypothalamus of rats treated with Cd 
(35, 51). As expected, melatonin significantly increased 
hippocampus GABA concentrations in the CdMlt group in 
our study, but it is interesting to note that the highest 
concentration was observed in the Mlt group. It seems that 
melatonin increases GABA accumulation in different parts 
of the brain tissue (52).
Another interesting finding was the lack of significant 
changes in the activity of AChE in the brain tissue in any 
of the groups in our study. Most importantly, AChE 
activities were not affected by melatonin treatment. In 
contrast, other studies reported a rise in the brain tissue of 
Cd-exposed rats treated with melatonin (17, 42), but this 
may be due to different dosage regimes.
Our histopathological exam showed that Cd caused 
severe multifocal changes and apoptotic cells in the cerebral 
cortex. Apoptosis may have been the result of increased 
caspase-3/7 activity, as reported by Mahdavi et al. (53). 
Apoptotic changes induced by Cd in cerebral cortical 
neurons were also reported by Yuan et al. (54). Melatonin 
seems to have attenuated these histopathological changes 
in our study, as we observed but a few multifocal areas and 
no apoptotic cells in the CdMlt group. This is in line with 
an earlier report of melatonin (4 mg/kg/day for eight weeks, 
i.p.) treatment reducing the loss in hippocampal neurons 
through direct blocking of Cd-induced oxidative stress 
pathways (14). Shagirtha et al. (17) also reported that oral 
melatonin pretreatment (10 mg/kg/day for four weeks) 
mitigated Cd-induced histopathological changes such as 
spongiform necrosis, nuclear vacuolisation, pycnosis, and 
lymphocytic inflammation in the rat brain tissue.
CONCLUSION
Our findings show that oral melatonin treatment has a 
great neuroprotective potential, especially against Cd 
neurotoxicity in the hippocampus and cerebral cortex and 
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Djelotvornost peroralne primjene melatonina u ublažavanju neurotoksičnosti izazvane kadmijem u Wistar štakora
Cilj je ovog istraživanja bio utvrditi djelovanje peroralne primjene melatonina na razine malondialdehida (MDA), glutationa 
(GSH), čimbenika nekroze tumora alfa (TNF-α), interleukina 6 i 10 (IL-6 i IL-10), enzimske aktivnosti katalaze (CAT), 
superoksid dismutaze (SOD) i acetilkolinesteraze (AChE) te na koncentraciju gama-aminomaslačne kiseline (GABA) u 
hipokampusnom tkivu Wistar štakora izloženih kadmiju (Cd). Također je cilj bio utvrditi histopatološke promjene u 
cerebralnom korteksu štakora. U tu je svrhu istraživanje obuhvatilo 32 mužjaka, nasumce raspoređena u četiri skupine: 
kontrolnu (n=8), skupinu koja je primala samo Cd (n=8), skupinu koja je primala samo melatonin (Mlt) (n=8) i skupinu 
koja je istodobno primala Cd + Mlt (n=8). Štakori u Cd i CdMlt skupinama primali su Cd u dozi od 2 mg/kg gavažom 
na usta triput na tjedan odnosno melatonin u dozi od 100 mg/kg na isti način pet puta na tjedan. Kontrolna je skupina 
primala samo vodu. Nakon četverotjednog tretmana životinje su dekapitirane te su uzeti uzorci tkiva za biokemijsku i 
histopatološku analizu. Primjena melatonina dovela je u CdMlt skupini do rasta razina GSH i SOD te aktivnosti katalaze 
u odnosu na skupinu koja je primala samo Cd. Potonja je pak iskazala značajno više tkivne razine TNF-α i IL-6 od ostalih 
skupina (P<0,05). Primjena melatonina dovela je do njihova značajnog sniženja u CdMlt skupini (P<0,05). Koncentracije 
GABA bile su pak značajno više u skupini na melatoninu nego u ostalim skupinama (P<0,05). Naši rezultati potvrđuju 
da melatonin štiti od neurotoksičnosti izazvane kadmijem u štakora.
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